Psychedelic Retreat Abroad Safety: What You Need to Know
Psychedelic tourism is growing fast, and so is the number of people booking retreats abroad with little more than a website and a payment link between...
San Pedro Mescaline Therapy: What to Know Before Considering This Path
San Pedro mescaline therapy draws on thousands of years of Andean ceremonial use and is now available at retreat centers in Peru, Ecuador, and other countries...
Psilocybin Eating Disorder Treatment: Early Evidence and Cautions
Psilocybin eating disorder treatment is an emerging area of clinical research, with early trials in anorexia nervosa showing that the compound is well-tolerated and may help...
How to Talk to Your Doctor About Psychedelic Therapy
Talking to your doctor about psychedelic therapy is one of the most common points where people get stuck. This guide walks you through how to frame...
Difficult Psychedelic Experience: What It Means and How Guides Help
A difficult psychedelic experience is not automatically a bad outcome. Research consistently shows that challenging moments during a journey can produce meaningful insights and lasting well-being...
Psychedelic Therapy Screening Assessment: What It Actually Looks At
A psychedelic therapy screening assessment is a structured clinical evaluation that determines whether psilocybin-assisted therapy is safe and appropriate for you, based on your psychiatric history,...
Psychedelic Therapy Contraindications: Who Should Pause First
Psychedelic therapy contraindications include a personal history of psychosis or mania, current lithium use, certain cardiac conditions, and active suicidal ideation with intent. Some of these...
What Happens in a Psychedelic Therapy Session: A Full Walk-Through
A professionally supported psychedelic experience is a structured, clinically informed process that unfolds across several weeks. Understanding what happens in a psychedelic therapy session requires looking...
Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found
Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...
Executive Burnout Psychedelic Therapy: What the Research Shows
Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.